Extracellular HMGB1 has been shown to interact with multiple cell surface receptors, most notably, receptor for advanced glycation end products (RAGE) and Toll-like receptor 4 (TLR4), to promote inflammation and tumor growth (41). Here, CD177 is linked to neoplasm.